Vanderbilt-Ingram Cancer Center — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center has participated in 536 clinical trials with 70 currently active.

Therapeutic areas: AML, Lung Cancer, Solid Tumors.

Sponsors: MacroGenics, Vanderbilt-Ingram Cancer Center, EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center?

Vanderbilt-Ingram Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center conducted?

Vanderbilt-Ingram Cancer Center has 536 clinical trials on record, with 70 currently active. Their work covers AML, Lung Cancer, Solid Tumors.

Is Vanderbilt-Ingram Cancer Center accredited by Crixeo Health?

Vanderbilt-Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.